Results 51 to 60 of about 664,130 (306)

Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles–rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh

Human Vaccines & Immunotherapeutics, 2019
Background: The new influx of Forcibly Displaced Myanmar Nationals (FDMNs) into Bangladesh started in August 2017 through different entry points of Bangladesh. Considering the imminent threat of infectious diseases outbreaks, the Government of Bangladesh
A. Khan, M. Islam, S. Siddique, Shakil Ahmed, N. Sheikh, A. U. Siddik, Muhammad Shariful Islam, F. Qadri   +7 more
semanticscholar   +1 more source

Stockpiling oral cholera vaccine

Bulletin of the World Health Organization, 2012
Cholera is re-emerging as a threat on the global public health stage. The number of reported cases worldwide is back at the peak level observed two decades ago,1 new Vibrio cholerae strains have appeared and antimicrobial resistance has increased. Weak surveillance systems and the possibility of travel and trade sanctions contribute to widespread ...
William Perea, Alejandro Costa, Stephen Martin   +2 more
openaire   +4 more sources

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

, 2007
Vietnam currently produces an orally administered, bivalent (O1 and O139) killed whole-cell vaccine and is the only country in the world with endemic cholera to use an oral cholera vaccine in public health practice.
Anh, Dang Duc, Attridge, Stephen, Canh, Do Gia, Carbis, Rodney, Clemens, John, Deen, Jacqueline, Han, Seung Hyun, Holmgren, Jan, Long, Phan Thi, Lopez, Anna Lena, Shin, Seong Hye, Son, Nguyen Hong, Thiem, Vu Dinh, von Seidlein, Lorenz   +13 more
core   +1 more source

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (Review) [PDF]

, 2013
Background Infection with enterotoxigenic Escherichia coli (ETEC) bacteria is a common cause of diarrhoea in adults and children in developing countries and is a major cause of 'travellers' diarrhoea' in people visiting or returning from endemic regions.
Ahmed, Tanvir, Bhuiyan, Taufiqur, Quadri, Firdausi, Sinclair, David, Zaman, K   +4 more
core   +3 more sources

Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011

Emerging Infectious Diseases, 2011
Oral cholera vaccines (OCVs) have been recommended in cholera-endemic settings and preemptively during outbreaks and complex emergencies. However, experience and guidelines for reactive use after an outbreak has started are limited. In 2010, after over a
Kashmira A. Date, Andrea Vicari, Terri B. Hyde, Eric D. Mintz, M. Carolina Danovaro-Holliday, Ariel Henry, Jordan W. Tappero, Thierry H. Roels, Joseph Abrams, Brenton T. Burkholder, Cuauhtémoc Ruiz-Matus, Jon Andrus, Vance Dietz   +12 more
doaj   +1 more source

Recombinant expression systems: the obstacle to helminth vaccines? [PDF]

, 2007
A
Claerebout, Edwin, De Maere, Veerle, Geldhof, Peter, Vercruysse, Jozef   +3 more
core   +2 more sources

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers

PLoS Neglected Tropical Diseases, 2018
Background Cholera is an acute voluminous dehydrating diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and occasionally O139. A growing body of evidence indicates that immune responses targeting the O-specific polysaccharide (OSP) of V.
K. Islam, Motaher Hossain, Meagan Kelly, Leslie M Mayo Smith, R. Charles, T. Bhuiyan, P. Kováč, Peng Xu, R. Larocque, S. Calderwood, J. Simon, Wilbur H. Chen, D. Haney, Michael D. Lock, Caroline E. Lyon, B. Kirkpatrick, Mitchell Cohen, M. Levine, M. Gurwith, J. Harris, F. Qadri, E. Ryan   +21 more
semanticscholar   +1 more source

Knowledge of Cholera Among Syrians: A Cross-Sectional Study

International Journal of Medical Students, 2022
Background: Cholera is a communicable acute bacterial infection caused by a gram-negative bacterium that is Vibrio Cholera. Worldwide, is estimated that an incidence of 1.3–4.0 millions of cholera infection, leading to 21,000–143,000 deaths annually ...
Mohammad Badr Almoshantaf, Sarya Swed , Hidar Alibrahim, Haidara Bohsas, Mohmad Nour Nasif, Wael Hafez, Ahmad Aldaas   +6 more
doaj  

Oral Vaccines Against Cholera [PDF]

Clinical Infectious Diseases, 2011
The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global ...
John D. Clemens, Sachin N. Desai, Sunheang Shin, Binod Sah   +3 more
openaire   +3 more sources

Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice

bioRxiv, 2019
Oral cholera vaccines (OCVs) are being increasingly employed, but current killed formulations generally require multiple doses and lack efficacy in young children.
B. Sit, Ting Zhang, Bolutife Fakoya, Aklima Akter, Rajib Biswas, E. Ryan, M. Waldor   +6 more
semanticscholar   +1 more source